Authors: Colby MaGill, MS4, Kaela Lakeland Ezell, M.S., John Walsh*, MD

PRINTABLE PDF

Background

Systemic vasculitides are a heterogeneous collection of conditions characterized by inflammation of the blood vessel wall with varying levels of tissue and end-organ injury. Vasculitis can affect vessels of any size and can present as either a systemic disease or limited to a single organ. Diagnosis often poses a challenge, given the highly variable and oftentimes overlapping clinical and pathologic features. 

Despite the breadth of vasculitis subtypes, they can generally be classified as either infectious or non-infectious. The two main mechanisms are either direct invasion of the vessel walls by infectious pathogens or non-infectious immune-mediated inflammation. 

Infectious arteritis results from direct invasion of bacteria (ex. Pseudomonas or rickettsial organisms) or fungi (ex. Aspergillus or Mucor species). Vascular infections can weaken the vascular walls and can culminate in mycotic aneurysms or induce a thrombosis. 

However, the majority of vasculitis cases fall under the noninfectious subtype. These subtypes are characterized based on the caliber of vessels affected (small, medium, or large). The main immunologic mechanisms underlying noninfectious vasculitis are immune complex deposition, antineutrophil cytoplasmic antibodies (ANCAs), antiendothelial cell antibodies, and/or autoreactive T cells. 

There are currently over 25 primary forms of noninfectious vasculitis according to the International Chapel Hill Consensus Conference on the Nomenclature of Systemic Vasculitides (CHCC). The main categories include: Large Vessel Vasculitis (LVV), Medium Vessel Vasculitis (MVV), Small Vessel Vasculitis (SVV), Variable Vessel Vasculitis (VVV), Single-organ Vasculitis (SOV), and vasculitis associated with systemic disease or probable etiology. An overview of these categories is summarized below in the figure and table below. 

The most recently updated society guidelines for the classification of vasculitis were published by the joint 2022 ACR/EULAR for the classification of ANCA-associated vasculitis. These updated criteria utilizes a weighted scoring framework across clinical, laboratory, radiological, and histological categories to classify disease subtypes.

Given the wide variety of vasculitis subtypes, this article will focus on the critical features of the most common large, medium, and small vessel vasculitides. 

Image: Diagram demonstrating the major categories of vasculitis (Image Credit: Jennette, Clin Exp Nephrol. 2013)

Categories Subtypes
Large Vessel Vasculitis (LVV) Takayasu arteritis
Giant cell arteritis
Medium Vessel Vasculitis (MVV) Polyarteritis nodosa
Kawasaki disease
Small Vessel Vasculitis (SVV) ANCA – associated vasculitis :
Microscopic polyangiitis
Granulomatosis with polyangiitis (Wegener’s)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Immune Complex:
Anti-GBM disease
Cryoglobulinemic vasculitis
IgA Vasculitis (Henoch-Schönlein)
Hypocomplementemic urticarial vasculitis (anti-C1q vasculitis)
Variable Vessel Vasculitis (VVV) Behcet’s disease
Cogan’s syndrome
Single Organ Vasculitis (SOV) Cutaneous leukocytoclastic angiitis
Cutaneous arteritis
Vasculitis Associated with Systemic Disease Lupus vasculitis
Rheumatoid vasculitis
Sarcoid vasculitis
Vasculitis Associated with Probable Etiology Hepatitis C virus-associated cryoglobulinemic vasculitis
Hepatitis B virus-associated vasculitis
Syphilis-associated aortitis
Drug-associated immune complex vasculitis
Drug-associated ANCA-associated vasculitis
Malignancy-associated vasculitis

Table: Subtypes of vasculitis (per 2012 CHCC, summarized by the authors)

Quick Tips at Time of Autopsy

Clinical History

  • Each subtype of vasculitis will demonstrate organ-specific symptoms based on extent of tissue involvement. However, most patients will present with constitutional signs and symptoms such as fever, myalgias, arthralgias, and malaise which are characteristic of systemic inflammation. Common presenting features are outlined in the table below.
  • Evaluate medication history carefully. Certain drugs, specifically the antithyroid medication propylthiouracil (PTU) as well as hydralazine and certain antibiotics can induce severe ANCA-associated vasculitis. 
  • Consider an underlying hematologic malignancy, particularly myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML), in older patients with unexplained vasculitis. Myeloid neoplasms carry a stronger vasculitis association than lymphoid malignancies; CMML specifically is linked to medium- and large-vessel patterns (PAN-like, GCA-like). Consider a CBC and bone marrow review when vasculitis is found without another explanation in an elderly decedent.

Table: Clinical features of major systemic vasculitides (Image Credit: Sharma et al., AAFP, 2011) note: Table terminology uses an older 1994 CHCC nomenclature)

Large Vessel

  • Neurologic: Giant cell arteritis (GCA) may present with tenderness of the scalp, headaches, visual disturbances, transient ischemic attacks, jaw claudication, or sudden blindness secondary to ophthalmic artery involvement. Takayasu arteritis could cause stroke symptoms, syncope, dizziness, or limb claudication due to major vessel stenosis.
  • Polymyalgia Rheumatica (PMR): Ask about a history of proximal myalgia – shoulder and hip girdle pain/stiffness. PMR co-occurs in a wide reported range of GCA patients (17–66%), and roughly 10% of isolated PMR cases go on to develop GCA. A history of PMR symptoms alongside temporal artery findings should raise suspicion for GCA
  • Cardiovascular: Takayasu arteritis commonly presents with absent or diminished peripheral pulses, discrepancies in blood pressure between extremities, aortic insufficiency, subclavian or carotid bruits, or congestive heart failure. Aneurysm or dissection of the thoracic aorta may occur.
  • Labs: Elevated CRP and ESR are characteristic. The presence of mild normocytic anemia may be observed. ANCA studies are usually negative.
  • Imaging: MR angiography or CT angiography may demonstrate concentric mural thickening, vessel occlusion, stenosis, aneurysmal dilation, or dissection of the major branches or aorta. The “halo sign” may be exhibited with GCA in temporal artery ultrasound. 

Medium Vessel

  • Neurologic: Polyarteritis nodosa (PAN) may commonly demonstrate peripheral neuropathy and mononeuritis multiplex.
  • Cardiovascular: Kawasaki disease may present with myocarditis, arrhythmias, coronary artery aneurysms, or sudden cardiac death due to coronary thrombosis.
  • Renal: Renal insufficiency and hypertension may occur secondary to involvement with the renal artery. Glomerulonephritis is absent unlike ANCA-associated vasculitis.
  • Skin: Purpura, ulcerations, livedo reticularis, digital ischemia, or tender subcutaneous nodules may be present.
  • Pediatrics: Kawasaki disease classically presents in children younger than five years old with conjunctivitis, fever, diffuse rash, oral mucosal erythema, cervical lymphadenopathy, and desquamation of the hands and feet.
  • Labs: Elevated CRP and ESR are common. ANCA studies are typically negative. In suspected PAN, Hepatitis B serologies should be reviewed.
  • Imaging: Angiography may reveal multiple small thromboses, stenoses, microaneurysms, or vessel irregularities in medium-sized arteries.

Small Vessel

  • Neurologic: Peripheral neuropathy; commonly mononeuritis multiplex
  • Renal: Rapidly progressive acute renal failure with resultant oliguria/anuria.
  • Pulmonary: Pulmonary hemorrhage w/ massive hemoptysis can be a life-threatening presentation.
  • Skin: Palpable purpura 
  • HEENT: GPA often involves the upper airways and can present with bloody nasal discharge, mucosal erosions, nasal septal perforations, and saddle nose deformity. Eye manifestations can include dacryocystitis, episcleritis, or granulomatous sclerouveitis. EGPA can present with asthma / allergic rhinitis history. 
  • Labs: Urinalysis may show proteinuria and/or hematuria if renal involvement. Look for elevated inflammatory markers such as ESR, CRP. Specific ANCA testing; PR3-ANCA (c-ANCA) typically aligns with GPA, while MPO-ANCA (p-ANCA) generally aligns with MPA or EGPA. 
  • Imaging: CT scans may demonstrate characteristic nodular and cavitation lung infiltrates in GPA.

Behcet’s: Look for a history of recurrent oral and genital ulcers, as well as eye involvement (such as uveitis or hypopyon).

Image: Characteristic lower extremity purpura of small vessel vasculitis (SVV) (Image Credit: Jennette et al. 1997)

Differential Diagnosis

  • Amyloidosis — large/medium vessel mimic (amyloid infiltration of the vessel wall)
  • Antiphospholipid Syndrome — small/medium vessel mimic (thrombotic occlusion, not true inflammatory vasculitis)
  • Atheroembolic Disease — large/medium vessel mimic (cholesterol emboli)
  • Atheromatous Vascular Disease — large/medium vessel mimic
  • Cocaine and Amphetamine Abuse — small/medium vessel mimic. Levamisole-adulterated cocaine specifically causes retiform purpura and necrosis concentrated on the bilateral ear helices and cheeks (also trunk/buttocks/legs), often with dual PR3/MPO-ANCA positivity or antibodies against human neutrophil elastase — an atypical pattern for primary AAV. See Toxicology under Ancillary Testing
  • Fibromuscular Dysplasia — medium vessel mimic (renal/carotid arteries, non-inflammatory)
  • Hypersensitivity Reactions — small vessel mimic (drug-induced leukocytoclastic vasculitis)
  • Infective Endocarditis — small/medium vessel mimic (septic emboli, mycotic aneurysms)
  • Multiple Myeloma — small vessel mimic (hyperviscosity, amyloid)
  • Paraneoplastic Syndromes — see the malignancy-associated vasculitis note under Clinical History; myeloid neoplasms (MDS, CMML) carry the strongest association
  • Sickle Cell Disease — small vessel mimic (vaso-occlusion)

Common secondary causes include:

  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus (SLE)
  • Scleroderma
  • Hepatitis A & C Infection
  • Lymphoma
  • Solid Organ Malignancy

External Examination

Large Vessel 

  • Temporal Arteries: Palpate and carefully inspect the temporal arteries for nodularity, thickening, tortuosity, or prominence typical of GCA. 
  • Extremities: Takayasu arteritis may present with muscle atrophy secondary to chronic vascular insufficiency.
  • General Appearance: Cachexia, evidence of chronic systemic inflammatory disease, or temporal wasting may be present.

Image: Prominent temporal artery typical in Temporal arteritis (Image Credit: WebPath).

Medium Vessel

  • Skin Lesions: PAN may present with palpable nodules, purpura, livedo reticularis, infarcts, ulcerations, or digital gangrene of the extremities.
  • Mucosal Findings: Kawasaki disease may exhibit oral erythema, conjunctival injection, and fissured lips.
  • Edema: Secondary to renal insufficiency or cardiac dysfunction, peripheral edema may occur.
  • Extremities: In the subacute phase of Kawasaki disease, desquamation of the palms and soles is characteristic.

Small Vessel

  • Skin lesions: The hallmark of cutaneous SVV is palpable purpura , most frequently seen on the lower extremities. Other signs include necrotic papules, livedo reticularis, vesicles, cutaneous infarcts, and frank wet gangrene of the digits or feet. 
  • Mucosal & Nodular Lesions: Mucosal erosions may be present, particularly in suspected Behcet’s disease; examine the oral & genital mucosa for ulcerations. Look for skin lesions that resemble acne or erythema nodosum. 
  • Edema/Anasarca: Look for generalized edema or anasarca that may have resulted from progressive renal failure, nephrotic syndrome, and volume overload. 
  • Nasal septal perforations and saddle nose deformity may be present in cases of GPA 

Image: Mucosal erosions seen on external exam of patient with ANCA-vasculitis (Image Credit: Fujii et al. 2024)

Image: Eye involvement of Granulomatosis with Polyangiitis. Note the eyelid edema, scleritis, chemosis, and subconjunctival hemorrhage. (Image Credit: Bîrluţiu et al. World Journal of Surgical Oncology (2016)). 

Image: Saddle nose deformity in a 51-year-old male with GPA (Image Credit: Pakalniskis et al. 2015).

Internal Examination

Large Vessel

  • Kidneys: Secondary hypertensive nephrosclerosis or chronic ischemic changes may be present.
  • Heart: Evaluate for heart failure secondary to chronic hypertension, aortic root dilation, coronary ostial narrowing, myocardial infarction, or aortic insufficiency. 
    • Aorta and Major Branches: Findings may include concentric wall thickening, stenosis, fibrosis, thrombosis, aneurysmal dilation, luminal narrowing, or dissection when the aorta and major branch vessels are carefully dissected.
  • Temporal Arteries: Thickened, nodular arteries with luminal narrowing and fibrosis may be revealed following serial sectioning.
  • Infectious (Syphilitic) Aortitis: A distinct large-vessel entity, not immune-mediated vasculitis — grossly demonstrates a wrinkled, scarred “tree-bark” appearance of the ascending aortic and arch intima, typically sparing the descending aorta (a useful distinguishing feature from atherosclerotic aneurysms, which favor the abdominal aorta). Look for aneurysm formation, aortic root dilation with valve ring involvement, and coronary ostial narrowing
  • Brain: Hemorrhage or cerebral infarcts may occur secondary to carotid or vertebral involvement.

Medium Vessel

  • Kidneys: Cortical scarring, ischemic changes, and renal infarcts are common in PAN due to involvement of the renal artery. Glomerulonephritis is typically absent.
  • GI Tract: Serosal hemorrhage, bowel ischemia, perforation, or transmural necrosis may result from mesenteric vasculitis. 
  • Heart: Myocardial infarction, coronary arteritis, thrombosis, aneurysm formation, or myocarditis may be observed, especially in Kawasaki disease.
    • Coronary Aneurysm Grading (Kawasaki Disease): Per AHA criteria, coronary aneurysms are graded by z-score and absolute diameter — small (z-score 2.5–<5), medium (z-score 5–<10, <8mm), and giant (z-score ≥10 or ≥8mm). Giant aneurysms carry substantial thrombosis risk that persists into adulthood; an unexplained calcified coronary aneurysm in a young or middle-aged sudden-death decedent should raise suspicion for an unrecognized childhood Kawasaki disease sequela
  • Peripheral Nervous System: Infarction or peripheral nerve ischemia may be identified in cases with severe mononeuritis multiplex
  • Liver: Periportal inflammation or hepatic infarcts may occasionally be present in PAN.

Small Vessel

  • Kidneys: Can have a “flea-bitten” appearance resulting from subcapsular petechial hemorrhages.
  • Lungs: Frequently heavy and edematous. In MPA, the lungs typically show hemorrhagic consolidation without discrete nodules. In GPA, expect to find multiple, well-circumscribed, bilateral nodular or cavitation lesions with areas of central necrosis. 
  • GI Tract: Discrete mucosal ulcers with central necrosis may be present in the stomach, ileum, or colon.
  • Heart: Fibrinous pericarditis and myocardial micro-infarcts are common. 
  • Brain: Subarachnoid hemorrhages or focal infarcts secondary to CNS small vessel vasculitis may be present. 

Image: Kidney demonstrating petechial hemorrhages i.e. “flea-bitten” appearance of small vessel vasculitis (SVV) (From: Kakkar, 2019)

Image: Gross lung section from patient with Granulomatosis with polyangiitis-large nodules with central cavitation in the left lung (Image Credit: PathologyOutlines)

Ancillary Testing

Large Vessel

  • Serology: Red top tube Postmortem ESR and CRP
    • ESR relies on intact, suspended red blood cells settling under gravity in fresh anticoagulated whole blood over a controlled interval; postmortem blood is typically hemolyzed, clotted, and gravitationally pooled well before collection, which invalidates the test’s basic physical assumptions. CRP is comparatively more stable postmortem but has not been validated against antemortem values in this setting either – interpret as supportive only
  • Imaging: Postmortem CT angiography
    • Postmortem CT angiography (PMCTA) is a validated adjunct to conventional autopsy for large-vessel disease, mapping the extent of a dissection, localizing a rupture site, or surveying the aorta and great vessels for aneurysmal or mycotic change prior to the autopsy. In a 500-body multicenter forensic study, PMCTA detected 94% of vascular lesions versus 65% for autopsy alone (90% vs. 61% of all forensically relevant findings overall) (Grabherr et al., Radiology 2018). It has also been used on a smaller scale to identify vascular lacerations and tears in trauma. 
  • Microbiology: Bacterial and fungal cultures for suspected infectious aortitis 

Medium Vessel

  • Serology: Hepatitis B surface antigen and serologies for suspected polyarteritis nodosa (PAN)
  • Imaging: Post-mortem CT angiography
  • Molecular Testing: In suspected infectious associations, send for viral PCR or immunohistochemistry. (Collect fresh or fresh-frozen tissue for PCR; formalin fixation cross-links and degrades nucleic acids and reduces PCR sensitivity, especially beyond ~2 weeks in formalin. Routine FFPE blocks are adequate for immunohistochemistry.)

Small Vessel

  • Serology: Post-mortem ANCA testing can be performed – plain red-top tube (no additives/no gel) 
    • Standard clinical ANCA immunoassays are validated on antemortem serum; validation for postmortem blood specifically has not been established. Postmortem IgG runs roughly 16% lower than antemortem on average, independent of postmortem interval — so a negative postmortem ANCA does NOT reliably exclude AAV. Interpret postmortem ANCA results as supportive, not exclusionary
  • Toxicology: Send toxicology when small-vessel changes with skin necrosis are present, particularly retiform purpura concentrated on the bilateral ear helices and cheeks – this distribution, especially with dual PR3/MPO-ANCA positivity or an atypical ANCA pattern, suggests levamisole-adulterated cocaine vasculitis rather than primary AAV
  • Complement Levels: C3/C4 complement levels help distinguish pauci-immune (ANCA-associated, normal complement) from immune-complex-mediated vasculitis (low complement) – most notably hypocomplementemic urticarial vasculitis (anti-C1q vasculitis), cryoglobulinemic vasculitis, and lupus vasculitis
  • Imaging: Post-mortem CT angiography can demonstrate intraluminal changes such as vessel wall thickening, arterial stenosis, and aneurysmal dilations. Additionally, CT evaluation of the chest and abdomen can reveal key systemic complications, including extensive bilateral lung consolidation, pleural effusions, and visceral organ infarctions.

Quick Tips at Time of Histology Evaluation

Histology

Large Vessel Vasculitis (LVV)

  • LVV primarily affects the aorta and its major branches. It is characterized by granulomatous inflammation centered on the media and internal elastic lamina.
    • Vascular Changes: Granulomatous arteritis is characterized by lymphocytes, multinucleated giant cells, and histiocytes. Destruction of the internal elastic lamina and fragmentation are common findings. Marked intimal fibrosis and luminal stenosis can be present in chronic lesions.
    • Temporal Artery Patterns: Patchy lesions with granulomatous inflammation involving the media are typically present in GCA. Disrupted elastic fibers are typically present adjacent to giant cells.Aortic Patterns: Granulomatous panarteritis with medial destruction, marked intimal hyperplasia, and adventitial fibrosis are present in Takayasu arteritis. The vascular lumen may be nearly or completely obliterated by advanced lesions.
    • Infectious (Syphilitic) Aortitis Pattern: Obliterative endarteritis and periarteritis of the vasa vasorum with a plasma cell-rich infiltrate, leading to medial elastic and smooth muscle destruction and irregular scarring. Three distinct fatal mechanisms result: aortic regurgitation from valve ring dilation, myocardial infarction from coronary ostial stenosis, and aneurysm rupture — the classic sudden-death mechanism in untreated tertiary syphilis

Medium Vessel Vasculitis (MVV)

  • MVV demonstrates segmental transmural inflammation with fibrinoid necrosis and primarily affects medium-sized muscular arteries.
    • Vascular Changes: Transmural necrotizing arteritis with fibrinoid necrosis and neutrophilic infiltration are shown with acute lesions. Fibrous thickening and luminal narrowing are demonstrated by chronic lesions. Commonly present within the same tissue specimen are lesions of varying degrees.
    • Renal Patterns: Helping to distinguish from ANCA-associated vasculitis, PAN typically affects renal arteries but spares glomeruli.
    • Cardiac Patterns: Coronary arteries are commonly involved in Kawasaki disease with transmural inflammation, thrombosis, subsequent fibrosis, and aneurysm formation. 
    • Immunofluorescence: In PAN, immune complex deposition is generally minimal or absent. Nonspecific inflammatory changes without characteristic immunofluorescence pattern may be shown in Kawasaki disease.

Small Vessel Vasculitis (SVV) 

  • SVV commonly affects the small intraparenchymal arteries, arterioles, capillaries, and venules. They are further subdivided based on paucity (ANCA-associated) or plethora (immune complex) of immunoglobulin deposition in the vessels.
    • Vascular Changes: The histopathologic hallmark of SVV is fibrinoid necrosis; this is characterized by the replacement of the vessel wall with amorphous, bright pink, eosinophilic material. This is accompanied by neutrophilic infiltration and nuclear debris (leukocytoclasia).
    • Renal Patterns: The classic finding among ANCA-associated vasculitis is pauci-immune focal and segmental necrotizing crescentic glomerulonephritis. Glomerulitis with total destruction of the glomerulus by polymorphs can occur in MPA, GPA, and EGPA. Fibrinoid necrosis is often seen extending into the glomerular tuft from the afferent arterioles. Immunofluorescence will show a paucity of immunoglobulin deposits (in AAV).
    • Grading Renal Involvement (Berden Classification): Percent-crescentic involvement should be reported using the  2010 Berden classification grades for ANCA-associated glomerulonephritis; classifications correlate to survival 
Class Criteria
Focal ≥50% normal glomeruli
Crescentic ≥50% glomeruli with cellular crescents
Mixed <50% normal, <50% crescentic, <50% globally sclerotic
Sclerotic ≥50% globally sclerotic glomeruli

Table: Berden (2010) Histopathologic Classification of ANCA-Associated Glomerulonephritis

  • Pulmonary Patterns: MPA typically features neutrophilic alveolar capillaritis and diffuse alveolar hemorrhage. GPA is characterized by necrotizing granulomatous inflammation with epithelioid histiocytes and multinucleated giant cells. EGPA demonstrates eosinophil-rich granulomatous inflammation. 

Immunofluorescence: 

  • Cytoplasmic ANCA (c-ANCA): Shows a granular cytoplasmic fluorescence . Antigen Target: Proteinase 3 (PR3), a neutral serine protease located in neutrophil azurophilic granules. Classically associated with Granulomatosis with Polyangiitis (GPA). Active systemic GPA demonstrates c-ANCA positivity in 85% to 98% of cases
  • Perinuclear ANCA (p-ANCA): Shows a perinuclear or nuclear staining pattern. Antigen Target: Myeloperoxidase (MPO), an enzyme involved in oxygen free radical generation. Most commonly found in Microscopic Polyangiitis (MPA) (60–70% of cases) and Eosinophilic Granulomatosis with Polyangiitis (EGPA) (30–38% of cases)
  • Immune Complex-Mediated Patterns: IgA Vasculitis (Henoch-Schönlein purpura): Characterized by predominant IgA-dominant immune deposits Deposits are typically concentrated in the walls of affected dermal capillaries, venules, or arterioles, as well as the renal mesangium
  • Cryoglobulinemic Vasculitis: Demonstrates moderate to marked deposition of IgG, IgM, and C3 within the vessel walls

Image: Patterns of antineutrophil cytoplasmic antibodies (ANCAs) (Image Credit: Clin Exp Rheumatol. 2014)

Image: Diffuse alveolar hemorrhage in a case of GPA (H&E, x40) (Image Credit: Pinckard, Acad Forensic Pathol. 2017)

Image: Renal arteriole with acute vasculitis (H&E, x200) (Image credit: (Pinckard, Acad Forensic Pathol. 2017)

Image: Anti-MPO related glomerulonephritis with segmental fibrinoid necrosis (Image Credits: PathologyOutlines)

Granulomatosus with Polyangiitis Blood vessel: Necrotizing small vessel vasculitis with granulomatous inflammation

Renal: Crescentic glomerulonephritis or pauci-immune necrotizing glomerulonephritis

Microscopic Polyangiitis Blood vessel: Necrotizing small vessel vasculitis without granulomatous inflammation

Renal: Crescentic glomerulonephritis and/or pauci-immune necrotizing glomerulonephritis 

Eosinophilic Granulomatosus with Polyangiitis Blood vessel: Eosinophil-rich necrotizing vasculitis associated with a granulomatous reaction
IgA Vasculitis Blood vessel: Predominant IgA deposition within vessel walls on direct immunofluorescence
Cryoglobulinemic Vasculitis Skin lesions: Leukocytoclastic vasculitis on light microscopy. Various combinations of IgG, IgM, and complement deposition on direct immunofluorescence
*Behcet Disease (Variable Vessel Vasculitis) Blood vessel: Perivasculitis with early neutrophil infiltration and endothelial swelling, diffuse inflammation of all layers of the vessel wall with pseudo-aneurysm formation and vasculitis of the vasa-vasorum.

Table: Histopathologic Findings of Small Vessel Vasculitis (adapted from Statpearls)

Special Stains

Elastic stains (e.g. Elastic Van Gieson) and Masson’s trichrome are important for demonstrating breakage, fragmentation, and/or total destruction of the internal elastic lamina. 

Image: Masson stain demonstrating rupture of the vessel wall (Image Credit:: Fujii et al, 2024)

Quick Tips at Time of Reporting

Patterns of cause of death in various vasculitides: 

  • Large Vessel (GCA/Takayasu): Death is a discrete event, such as aortic dissection or rupture from an aortitis-weakened wall, ischemic stroke from carotid/vertebral occlusion, or myocardial infarction from coronary ostial narrowing. Document which of these mechanisms occurred, when possible. 
  • Medium Vessel — Polyarteritis Nodosa: Three distinct sufficient mechanisms most commonly occur: bowel perforation from transmural mesenteric necrosis, multi-infarct kidneys with malignant hypertension, and microaneurysm rupture (hepatic, renal, or mesenteric) resulting in fatal hemorrhage.
  • Medium Vessel — Kawasaki Disease: Coronary thrombosis of an aneurysm (see Coronary Aneurysm Grading under Internal Examination), acutely in childhood or decades later in adulthood
  • Small Vessel/AAV: Two dominant, often combined mechanisms, diffuse alveolar hemorrhage causing hypoxemic respiratory failure, and rapidly progressive (majority-crescentic, per the Berden classification) glomerulonephritis causing uremic renal failure
  • Incidental vs. Fatal Findings: Scattered small-vessel changes found without a corresponding gross catastrophic event or organ failure (e.g.leukocytoclastic vasculitis in skin, mild non-crescentic glomerular changes) should not be over-called as the cause of death. 

Differential diagnoses:

  • Large & Medium Vessel
    • Differentiating LVV subtypes: Takayasu arteritis and giant cell arteritis share overlapping granulomatous histology where distinction relies heavily on vessel distribution, clinical presentation, and patient age.
    • Differentiating PAN from AAV: Helping distinguish it from microscopic polyangiitis, polyarteritis nodosa lacks glomerulonephritis and pulmonary capillaritis. 
    • Carefully Document: Distribution of vascular involvement; Presence of dissection, aneurysm, or thrombosis; Evidence of ischemic organ injury; Presence or absence of granulomatous inflammation; Degree of luminal stenosis.
  • Small Vessel
    • Differentiating AAV subtypes: The renal histologic lesions of MPA and GPA are nearly identical. The defining distinction relies heavily on the respiratory tract findings. The presence of granulomatous inflammation and geographic necrosis confirms GPA, whereas isolated pulmonary capillaritis with hemorrhage points to MPA.

Examples of Cause of Death Statements:

  1. “Ruptured thoracic aortic dissection due to giant cell aortitis.”
  2. “Acute renal failure secondary to rapidly progressive glomerulonephritis due to microscopic polyangiitis.” 
  3. “Massive pulmonary hemorrhage with concomitant renal failure secondary to granulomatosis with polyangiitis.”
  4. “Mesenteric ischemia and bowel necrosis due to polyarteritis nodosa.”
  5. “Acute myocardial infarction due to coronary artery thrombosis secondary to Kawasaki disease.”

References

  1. Cotran, R. S.; Robbins, S. L. Robbins, Cotran & Kumar Pathologic Basis of Disease, Eleventh edition.; Kumar, V., Abbas, A. K., Aster, J. C., Debnath, J., Das, A., Eds.; Elsevier: Philadelphia, PA, 2026.
  2. Jatwani S, Blum MA. Vasculitis. [Updated 2025 Dec 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545186/
  3. Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013 Oct;17(5):603-606. doi: 10.1007/s10157-013-0869-6. Epub 2013 Sep 27. PMID: 24072416; PMCID: PMC4029362.
  4. Fujii G, Yoshihara R, Hyodo T, Ishida I, Onishi R, Fujimoto M, Iida K. An Autopsy Case of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Induced by Propylthiouracil. Intern Med. 2024 Dec 1;63(23):3197-3202. doi: 10.2169/internalmedicine.3397-23. Epub 2024 Apr 9. PMID: 38599866; PMCID: PMC11671207.
  5. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997 Nov 20;337(21):1512-23. doi: 10.1056/NEJM199711203372106. PMID: 9366584. 
  6. Pinckard JK. A Case of Granulomatosis with Polyangiitis Diagnosed at Autopsy. Acad Forensic Pathol. 2017 Jun;7(2):288-298. doi: 10.23907/2017.026. Epub 2017 Jun 1. PMID: 31239978; PMCID: PMC6474535. 
  7. Auen T, Linde E. An Autopsy Case of ANCA-Negative Small Vessel Vasculitis With Glomerular Crescents. Am J Forensic Med Pathol. 2025 Jun 23. doi: 10.1097/PAF.0000000000001058. Epub ahead of print. PMID: 40539888. 
  8. Zhe Zheng, Hongli Xiong, Li Zhang, Congcong Zhao, Yongguo Li, Jianbo Li, Investigating the forensic pathological characteristics of systemic vasculitis: A retrospective study of 20 deaths caused by systemic vasculitis, Journal of Forensic and Legal Medicine, Volume 81, 2021, 102204, ISSN 1752-928X, https://doi.org/10.1016/j.jflm.2021.102204.
  9. Caroline Capuani, Céline Guilbeau-Frugier, Fatima-Zohra Mokrane, Marie-Bernadette Delisle, Bertrand Marcheix, Hervé Rousseau, Norbert Telmon, Daniel Rougé, Fabrice Dedouit, Tissue microscopic changes and artifacts in multi-phase post-mortem computed tomography angiography in a hospital setting: A fatal case of systemic vasculitis, Forensic Science International, Volume 242, 2014, Pages e12-e17, ISSN 0379-0738, https://doi.org/10.1016/j.forsciint.2014.06.039.
  10. Systemic vasculitis, POONAM SHARMA, MBBS, SANJEEV SHARMA, MD, RICHARD BALTARO, MD, AND JOHN HURLEY, MD, Am Fam Physician. 2011;83(5):556-565
  11. Nicklin A, Byard RW. Lethal manifestations of systemic lupus erythematosus in a forensic context. J Forensic Sci. 2011 Mar;56(2):423-8. doi: 10.1111/j.1556-4029.2010.01683.x. Epub 2011 Feb 9. PMID: 21306376. 
  12. Hasegawa J, Wakai S, Kono M, Imaizumi Y, Masuda S, Ishizu A, Honda K. An Autopsy Case of Myeloperoxidase-anti-neutrophil Cytoplasmic Antibody (MPO-ANCA)-associated Vasculitis Accompanied by Cryoglobulinemic Vasculitis Affecting the Kidneys, Skin, and Gastrointestinal Tract. Intern Med. 2018 Sep 15;57(18):2739-2745. doi: 10.2169/internalmedicine.0720-17. Epub 2018 Apr 27. PMID: 29709950; PMCID: PMC6191583.
  13. Müller A, Krause B, Kerstein-Stähle A, Comdühr S, Klapa S, Ullrich S, Holl-Ulrich K, Lamprecht P. Granulomatous Inflammation in ANCA-Associated Vasculitis. Int J Mol Sci. 2021 Jun 17;22(12):6474. doi: 10.3390/ijms22126474. PMID: 34204207; PMCID: PMC8234846.
  14. Langford CA, Fauci AS. The Vasculitis Syndromes. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson J, Loscalzo J, Holland SM, Langford CA. eds. Harrison’s Principles of Internal Medicine, 22nd Edition. McGraw Hill; 2025. Accessed April 19, 2026. https://accessmedicine-mhmedical-com.usu01.idm.oclc.org/content.aspx?bookid=3541&sectionid=294355419
  15. Nandita Bharadwaj Kakkar, 101 Medical Autopsy Cases: Adult & Pediatric, 2019, Jaypee Brothers Medical Publishers. 
  16. Heitkötter B, Kuhnen C, Schmidt S, Wittschieber D. Granulomatosis with polyangiitis (Wegener’s granulomatosis): a rare variant of sudden natural death. Int J Legal Med. 2018 Jan;132(1):243-248. doi: 10.1007/s00414-017-1723-2. Epub 2017 Oct 31. PMID: 29086054.
  17. Ana Belén Larqué, (11 January 2021),  Pauci-immune complex crescentic glomerulonephritis / ANCA associated vasculitis, PathologyOutlines.com; https://www.pathologyoutlines.com/topic/kidneyANCArelatedgngen.html
  18. Pugh D, Karabayas M, Basu N, et al. Large vessel vasculitis. Nat Rev Dis Primers. 2022;7:93. https://pmc.ncbi.nlm.nih.gov/articles/PMC9115766/
  19. Reisch M, Thiel J, Bosch P. Large Vessel Vasculitis: Recent Advances in Pathophysiology and Targeted Therapies. Drugs. 2026. https://link.springer.com/article/10.1007/s40265-026-02323-z
  20. Howard T, Ahmad K, Swanson JA, Misra S. Polyarteritis Nodosa. Tech Vasc Interv Radiol. 2014;17(4):247-251. https://pmc.ncbi.nlm.nih.gov/articles/PMC4363102/ 
  21. Lin YC, Kalot MA, Husainat N, et al. Polyarteritis Nodosa: A Systematic Review of Test Accuracy and Benefits and Harms of Common Treatments. ACR Open Rheumatol. 2021;3(2):91-100. https://pmc.ncbi.nlm.nih.gov/articles/PMC7882539/
  22. Rott KT. Vasculitides. FP Essentials. 2019;486:11-18. https://pmc.ncbi.nlm.nih.gov/articles/PMC7193731/
  23. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. 2014;371:50-57. https://pmc.ncbi.nlm.nih.gov/articles/PMC4277693/
  24. Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11. https://onlinelibrary.wiley.com/doi/10.1002/art.37715
  25. Hellmich B, Agueda A, Monti S, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for giant cell arteritis. Ann Rheum Dis. 2022;81(12):1647-1653. https://ard.eular.org/article/S0003-4967(24)08730-2/fulltext
  26. Grayson PC, Ponte C, Suppiah R, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for Takayasu arteritis. Ann Rheum Dis. 2022;81(12):1654-1660. https://acrjournals.onlinelibrary.wiley.com/doi/full/10.1002/art.42324
  27. Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis. Ann Rheum Dis. 2010;69(5):798-806. https://ard.eular.org/article/S0003-4967(24)19507-6/abstract
  28. Eleftheriou D, Levin M, Shingadia D, et al. Management of Kawasaki disease. Arch Dis Child. 2014;99(1):74-83. https://pmc.ncbi.nlm.nih.gov/articles/PMC3888612/
  29. Pyo JY, Lee LE, Park YB, Lee SW. Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria. Yonsei Med J. 2023 Jan;64(1):11-17. doi: 10.3349/ymj.2022.0435. PMID: 36579374; PMCID: PMC9826961.
  30. Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628-1636. doi:10.1681/ASN.2010050477. 
  31. Nesher G, Breuer GS. Giant cell arteritis and polymyalgia rheumatica: 2016 update. Rambam Maimonides Med J. 2016;7(4):e0035. doi:10.5041/RMMJ.10262. 
  32. Del Re F, Falcetta GS, Pratali S, Belgio B, Pucci A, Bortolotti U. Syphilitic Aortic Aneurysm in the Third Millennium. AORTA. 2018;6(5):118-119. doi:10.1055/s-0039-1683399. 
  33. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135(17):e927-e999. doi:10.1161/CIR.0000000000000484. 
  34. Larscheid G, Schulz T, Herbst H, et al. Comparison of total immunoglobulin G in ante- and postmortem blood samples from tissue donors. Transfus Med Hemother. 2021;48(1):32-38. doi:10.1159/000513662. 
  35. Chung C, Tumeh PC, Birnbaum R, et al. Characteristic purpura of the ears, vasculitis, and neutropenia – a potential public health epidemic associated with levamisole-adulterated cocaine. J Am Acad Dermatol. 2011;65(4):722-725. doi:10.1016/j.jaad.2010.08.024. 
  36. Grabherr S, Heinemann A, Vogel H, et al. Postmortem CT Angiography Compared with Autopsy: A Forensic Multicenter Study. Radiology. 2018;288(1):270-276. doi:10.1148/radiol.2018170559. 
  37. Watanabe R, Kiji M, Hashimoto M. Vasculitis associated with VEXAS syndrome: A literature review. Front Med. 2022;9:983939. doi:10.3389/fmed.2022.983939. 
  38. Roupie AL, Guedon A, Terrier B, et al. Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study. Semin Arthritis Rheum. 2020;50(5):879-884. doi:10.1016/j.semarthrit.2020.07.002.

* The views expressed in this article are those of the author(s) and do not necessarily reflect the official policy or position of the Department of Navy, Uniformed Services University of the Health Sciences, Defense Health Agency, U.S. Navy Bureau of Medicine and Surgery, Department of War, or the US Government. The authors report no conflict of interest or sources of funding.